A new normal for hypertension medicine with coronavirus disease-2019 (COVID-19): proposal from the president of the Japanese Society of Hypertension

por Itoh, Hiroshi
Publicado 2020

Nonalbuminuric Renal Insufficiency: Can It Be a Novel Category of Diabetic Nephropathy?

por Tanaka, Masami, Itoh, Hiroshi
Publicado 2016

Hypertension as a Metabolic Disorder and the Novel Role of the Gut

por Tanaka, Masami, Itoh, Hiroshi
Publicado 2019

Vaccine Development against the Renin-Angiotensin System for the Treatment of Hypertension

por Azegami, Tatsuhiko, Itoh, Hiroshi
Publicado 2019

“Greedy Organs Hypothesis” for sugar and salt in the pathophysiology of non-communicable diseases in relation to sodium-glucose co-transporters in the intestines and the kidney

por Itoh, Hiroshi, Tanaka, Masami
Publicado 2022

Sirtuin and metabolic kidney disease

por Wakino, Shu, Hasegawa, Kazuhiro, Itoh, Hiroshi
Publicado 2015

Transcription Factors as Therapeutic Targets in Chronic Kidney Disease

por Hishikawa, Akihito, Hayashi, Kaori, Itoh, Hiroshi
Publicado 2018

Circulating S100A8/A9 is potentially a biomarker that could reflect the severity of experimental colitis in rats

por Okada, Kohki, Itoh, Hiroshi, Ikemoto, Masaki
Publicado 2020

Effects of High Glucose and Lipotoxicity on Diabetic Podocytes

por Nakamichi, Ran, Hayashi, Kaori, Itoh, Hiroshi
Publicado 2021

Serum complement C3 and α(2)-macroglobulin are potentially useful biomarkers for inflammatory bowel disease patients

por Okada, Kohki, Itoh, Hiroshi, Ikemoto, Masaki
Publicado 2021

Effects of temperature and phytoplankton community composition on subitaneous and resting egg production rates of Acartia omorii in Tokyo Bay

por Tsunashima, Ayumi, Itoh, Hiroshi, Katano, Toshiya
Publicado 2021

Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?

por Sasaki, Hironobu, Itoh, Arata, Itoh, Hiroshi
Publicado 2022

Angiotensin II Reduces Mitochondrial Content in Skeletal Muscle and Affects Glycemic Control

por Mitsuishi, Masanori, Miyashita, Kazutoshi, Muraki, Ayako, Itoh, Hiroshi
Publicado 2009

Severe systemic calciphylaxis with culture-negative endocarditis

por Azegami, Tatsuhiko, Wakino, Shu, Hayashi, Matsuhiko, Itoh, Hiroshi
Publicado 2013

Pharmacokinetics and pharmacodynamics of mepolizumab, an anti–interleukin 5 monoclonal antibody, in healthy Japanese male subjects

por Tsukamoto, Naohiro, Takahashi, Naoki, Itoh, Hiroshi, Pouliquen, Isabelle
Publicado 2015

Revisiting Regulators of Human β-cell Mass to Achieve β-cell–centric Approach Toward Type 2 Diabetes

por Sasaki, Hironobu, Saisho, Yoshifumi, Inaishi, Jun, Itoh, Hiroshi
Publicado 2021

Epigenetic Alterations in Podocytes in Diabetic Nephropathy

por Sugita, Erina, Hayashi, Kaori, Hishikawa, Akihito, Itoh, Hiroshi
Publicado 2021

Differential Effects in Cardiovascular Markers between High-Dose Angiotensin II Receptor Blocker Monotherapy and Combination Therapy of ARB with Calcium Channel Blocker in Hyperten...

por Kinouchi, Kenichiro, Ichihara, Atsuhiro, Bokuda, Kanako, Kurosawa, Hideaki, Itoh, Hiroshi
Publicado 2011

Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study

por Ito, Sadayoshi, Itoh, Hiroshi, Rakugi, Hiromi, Okuda, Yasuyuki, Yamakawa, Satoru
Publicado 2019

Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label...

por Itoh, Hiroshi, Ito, Sadayoshi, Rakugi, Hiromi, Okuda, Yasuyuki, Nishioka, Satoshi
Publicado 2019